Literature DB >> 16865569

Panic attack with suicide: an exceptional adverse effect of infliximab.

Xavier Roblin, Paula Oltean, Frederic Heluwaert, Bruno Bonaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16865569     DOI： 10.1007/s10620-006-8007-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  4 in total

1.  Clinical experience with infliximab therapy in 100 patients with Crohn's disease.

Authors:  R J Farrell; S A Shah; P J Lodhavia; M Alsahli; K R Falchuk; P Michetti; M A Peppercorn
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

2.  Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy.

Authors:  Knut A Hestad; Sverre Tønseth; Charlotte D Støen; Thor Ueland; Pål Aukrust
Journal:  J ECT       Date:  2003-12       Impact factor: 3.635

3.  Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients.

Authors:  Piotr Trzonkowski; Jolanta Myśliwska; Beata Godlewska; Ewa Szmit; Krzysztof Łukaszuk; Joanna Wieckiewicz; Lidia Brydak; Magdalena Machała; Jerzy Landowski; Andrzej Myśliwski
Journal:  Brain Behav Immun       Date:  2004-03       Impact factor: 7.217

4.  The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.

Authors:  Jean-Frederic Colombel; Edward V Loftus; William J Tremaine; Laurence J Egan; W Scott Harmsen; Cathy D Schleck; Alan R Zinsmeister; William J Sandborn
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682
  4 in total
  1 in total

1.  Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database.

Authors:  Eve-Marie Thillard; Sophie Gautier; Evgeniya Babykina; Louise Carton; Ali Amad; Guillaume Bouzillé; Jean-Baptiste Beuscart; Grégoire Ficheur; Emmanuel Chazard
Journal:  Front Pharmacol       Date:  2020-04-22       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.